Offer - Urjas Oil for just ₹ 1 X
Nebula 2.5 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of High BP.
The optimal dosage of Nebula 2.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Nebula 2.5 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Nebula 2.5 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Nebula 2.5 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to Nebula 2.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Nebula 2.5 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. The section on Nebula 2.5 Tablet contraindications lists all such conditions.
Drug reaction of Nebula 2.5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Nebula 2.5 Tablet is not safe while driving, and is not addiction.
Nebula 2.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebula 2.5 Tablet safe for pregnant women?
Nebula shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebula 2.5 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Nebula. So it is adviced to consult the doctor before using it.
What is the effect of Nebula 2.5 Tablet on the Kidneys?
Nebula may have mild side effects on the kidneys.
What is the effect of Nebula 2.5 Tablet on the Liver?
Side effects of Nebula rarely affect the liver.
What is the effect of Nebula 2.5 Tablet on the Heart?
Nebula has very mild side effects on the heart.
Nebula 2.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nebula 2.5 Tablet unless your doctor advises you to do so -
Is this Nebula 2.5 Tablet habit forming or addictive?
Forming a habit of Nebula 2.5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nebula 2.5 Tablet, you should not drive or work on any heavy machine, as Nebula 2.5 Tablet can make you drowsy.
Is it safe?
Yes, but take Nebula 2.5 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Nebula 2.5 Tablet is not used to treat mental disorders.
Interaction between Food and Nebula 2.5 Tablet
When consumed with certain foods, Nebula 2.5 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nebula 2.5 Tablet
Consuming Nebula 2.5 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897